Cancer Nanotechnology · 2017 · 72 citations · 78 references
EngineeringMolecular BiologyOncologyBiomedical OpticsBiosensorsNanotechnologyCancer NanomedicineNanomaterial-based BiosensorsNanomedicineOptical BiosensorsPlasmonic NanomaterialsPlasmonicsNanomaterial-based Optical BiosensorsNanoparticle-based BiosensorsNanoparticle-based ProbesNanostructuresPlasmonic BiosensorsPlasmonic NanostructuresSurface-enhanced Raman ScatteringSurface-enhanced Raman Scattering Biosensors
Early diagnosis, monitoring and treatment selection of cancer represent major challenges in medicine. The definition of the complex clinical and molecular landscape of cancer requires the combination of multiple techniques and the investigation of multiple targets. As a result, diagnosis is normally lengthy, expensive and, in many cases, cannot be performed recursively. In recent years, optical biosensors, especially those based on the unique properties of plasmonic nanostructures, have emerged as one of the most exciting tools in nanomedicine, capable of overcoming key limitations of classical techniques. In this review, we specifically focus our attention on the latest advances in optical biosensors exploiting surface-enhanced Raman scattering encoded particles for the characterization of tumor single cells (molecular biology) and tissues (immunohistochemistry and guided surgery), as well as their application in guided surgery or even in bioimaging of living organisms.
78
Prashant K. Jain, Xiaohua Huang, Ivan H. El‐Sayed et al. · Accounts of Chemical Research · 2008 · 4.1K citations
Natural Sciences, Biomedical Engineering, Materials Science +17
Methods for Staging Non-small Cell Lung Cancer
Gerard A. Silvestri, Anne V. Gonzalez, Michael A. Jantz et al. · CHEST Journal · 2013 · 1.5K citations